Ensysce Biosciences, Inc.ENSCNASDAQ
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank71
Year-over-Year Change
Price-to-earnings ratio
Latest
-1.78
↑ 100% vs avg
Percentile
P71
Within normal range
Streak
1 yr
Consecutive growthElevated
Average
-407610.53
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2024 | -1.78 | +47.5% |
| 2023 | -3.39 | -237.5% |
| 2022 | -1.00 | +97.9% |
| 2021 | -48.88 | -100.0% |
| 2020 | 3515272.39 | +15642.5% |
| 2019 | -22617.23 | +85.7% |
| 2018 | -158096.88 | +97.6% |
| 2017 | -6595387.43 | - |